Immunotherapy of myeloid leukaemia.

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	943-957
Number of pages	15
Journal	Cancer immunology, immunotherapy : CII
Volume	56(7)
Issue number	7
DOIs	https://doi.org/10.1007/s00262-006-0267-y
Publication status	Published - Jul 2007

ASJC Scopus subject areas

This output contributes to the following UN Sustainable Development Goals (SDGs)

@article{bcacddf29e0c433c964021fcfa27d8ec,

title = "Immunotherapy of myeloid leukaemia.",

author = "Ken Mills",

year = "2007",

month = jul,

doi = "10.1007/s00262-006-0267-y",

language = "English",

volume = "56(7)",

pages = "943--957",

journal = "Cancer immunology, immunotherapy : CII",

issn = "1432-0851",

publisher = "Springer Science and Business Media Deutschland GmbH",

number = "7",

}

TY - JOUR

T1 - Immunotherapy of myeloid leukaemia.

AU - Mills, Ken

PY - 2007/7

Y1 - 2007/7

UR - http://www.scopus.com/inward/record.url?scp=34247635780&partnerID=8YFLogxK

U2 - 10.1007/s00262-006-0267-y

DO - 10.1007/s00262-006-0267-y

M3 - Article

C2 - 17180671

SN - 1432-0851

VL - 56(7)

SP - 943

EP - 957

JO - Cancer immunology, immunotherapy : CII

JF - Cancer immunology, immunotherapy : CII

IS - 7

ER -